CHAMPIONS ONCOLOGY, INC.
For the period ended Jan 31, 2026. Filed Mar 12, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jan 31, 2026 · Filed Mar 12, 2026
CSBR$4.84+1.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| CHAMPIONS ONCOLOGY, INC. | ||
| (Registrant) | ||
| Date: March 12, 2026 | By: | /s/ Robert Brainin |
|---|---|---|
| Robert Brainin | ||
| Chief Executive Officer | ||
| (principal executive officer) | ||
| Date: March 12, 2026 | By: | /s/ David Miller |
| David Miller | ||
| Chief Financial Officer | ||
| (principal financial and accounting officer) | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.